Millennium Management’s Intelligent Bio Solutions INBS Stock Holding History

Millennium Management’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	-$9K	–	7255
2022 Q2	$9K	Sell	6 -6	-50%	-$10.1K	﹤0.01%	6691
2022 Q1	$22K	Buy	+12	New	+$27.6K	﹤0.01%	6622

Other funds holding INBS

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management's INBS Position: Q3 2022 in Review

Millennium Management sold out of Intelligent Bio Solutions (INBS) in Q3 2022, closing a stake of 6 shares — an estimated $9K sold.

Millennium Management first reported a position in INBS in Q1 2022 and held it in 2 quarters. The position peaked at $22K in Q1 2022. 8 funds tracked by Wall St. Rank hold INBS as of Q3 2022.

Millennium Management reported no remaining Intelligent Bio Solutions position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 6 Intelligent Bio Solutions shares in Q3 2022, an estimated $9K.
Millennium Management first reported a position in Intelligent Bio Solutions in Q1 2022 and held it in 2 quarters.
Millennium Management's Intelligent Bio Solutions position peaked at $22K in Q1 2022.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.